Protection of normal human bone cells from Apo2L/TRAIL and chemotherapeutic drug combination-induced apoptosis

Simple item page
dc.contributor.authorFindlay, D.
dc.contributor.authorBouralexis, S.
dc.contributor.authorAtkins, G.
dc.contributor.authorChai, F.
dc.contributor.authorHay, S.
dc.contributor.authorClayer, M.
dc.contributor.authorEvdokiou, A.
dc.date.issued2001
dc.descriptionPoster presentations
dc.description.statementofresponsibilityD. M. Findlay, S. Bouralexis, G. J. Atkins, F. Chai, S. Hay, M. T. Clayer, A. Evdokiou
dc.description.urihttp://www.elsevier.com/wps/find/journaldescription.cws_home/525233/description#description
dc.identifier.citationBone, 2001; 28(5):S137-S137
dc.identifier.doi10.1016/S8756-3282(01)00454-9
dc.identifier.issn8756-3282
dc.identifier.orcidAtkins, G. [0000-0002-3123-9861]
dc.identifier.orcidEvdokiou, A. [0000-0001-8321-9806]
dc.identifier.urihttp://hdl.handle.net/2440/38789
dc.language.isoen
dc.publisherElsevier Science Inc
dc.titleProtection of normal human bone cells from Apo2L/TRAIL and chemotherapeutic drug combination-induced apoptosis
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications